The role of suprahyoid neck dissection in the treatment of squamous cell carcinoma of the lower lip: 20 years' experience at a Tertiary Center

Kuşçu, Oğuz; Bajin, Münir Demir; Süslü, Nilda; Hoşal, Ali Şefik

doi:10.1016/j.jcms.2016.06.004

Cited by 11 publications

(10 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For example, the lower lip drains into the submental, submandibular and upper cervical lymph nodes (levels Ia, Ib and II according to Robbins et al. ) . If feasible, selective functional neck dissection should be performed, as this approach spares functionally vital structures (especially nerves, muscles and vessels).…”

Section: Surgical and Systemic Treatment Of Csccmentioning

confidence: 99%

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease

Leiter

Heppt

Steeb

et al. 2020

J Deutsche Derma Gesell

110

View full text Add to dashboard Cite

Summary Actinic keratoses (AKs) are common lesions in light‐skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence‐based framework for clinical decision making, the guidelines for actinic keratosis and cutaneous squamous cell carcinoma were developed using the highest level of methodology (S3) according to regulations issued by the Association of Scientific Medical Societies in Germany (AWMF). The guidelines are aimed at dermatologists, general practitioners, ENT specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office‐based settings as well as other medical specialties involved in the diagnosis and treatment of patients with AKs and cSCC. The guidelines are also aimed at affected patients, their relatives, policy makers and insurance funds. In the second part, we will address aspects relating to epidemiology, etiology, surgical and systemic treatment of cSCC, follow‐up and disease prevention, and discuss AKs and cSCC in the context of occupational disease regulations.

show abstract

Section: Surgical and Systemic Treatment Of Csccmentioning

confidence: 99%

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease

Leiter

Heppt

Steeb

et al. 2020

J Deutsche Derma Gesell

110

View full text Add to dashboard Cite

show abstract

“…The common understanding concerning elective neck dissection in head and neck cancers is that there is a 15% to 20% rate of regional metastasis. [15][16][17] Califano et al [18] argue that capsule rupture and tumor size are the most important parameters regarding the development of cervical metastasis. It is known that tumors surrounded by a large lymphocyte band and well-differentiated carcinomas develop less cervical metastasis.…”

Section: Discussionmentioning

confidence: 99%

Neck dissection indications in lower lip squamous cell carcinoma cases: Our experience in 96 cases

Irmak¹

2019

South Clin Ist Euras

View full text Add to dashboard Cite

Objective: Squamous cell carcinoma (SCC) is the most common lip carcinoma and nodal status is the single most important prognostic factor. Though surgery is the first choice of treatment in early-stage cases, elective neck dissection to treat an eventual occult metastasis is still a matter of discussion. Methods: A total of 96 patients with lower lip SCC who were operated on in a single clinic between January 2005 and July 2017 were included in this study. Patients who did and did not undergo elective neck dissection after tumor resection according to risk and nodal status were studied in terms of age, gender, tumor size, and neck dissection type. Results: Among 96 patients, 74 were classified as T1-2N0 according to the American Joint Committee on Cancer staging system, and 30 underwent elective neck dissection. Among these 30 patients, 6 were diagnosed with metastasis. A total of 51 of the 96 members of the study group underwent elective supraomohyoid neck dissection. In all, 23 patients were diagnosed with metastasis. Conclusion: Lower lip SCC is a cancer with a relatively good prognosis, but regional lymph node metastasis decreases the survival rate substantially. In selected cases, staging the tumor via supraomohyoid neck dissection or sentinel lymph node biopsy is adequate to detect occult metastasis and prevent late lymph node metastasis.

show abstract

“…Für einige wenige Lokalisationen wird ein recht konstanter Lymphabflussbereich beschrieben, so zum Beispiel für den Bereich der Unterlippe der Lymphabfluss in die submentalen und submandibulären Lymphknoten sowie hoch‐zervikalen Lymphknoten (Level Ia, Ib und II nach Robbins et al. ) . Wenn möglich sollte eine schonende, sogenannte selektiv‐funktionelle Ausräumung unter Erhalt der funktionell bedeutsamen Strukturen (insbesondere Nerven, Muskeln und Gefäße) erfolgen.…”

Section: Operative Und Systemische Therapie Des Pekunclassified

S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit

Leiter

Heppt

Steeb

et al. 2020

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Zusammenfassung Aktinische Keratosen (AK) sind häufige Hautveränderungen bei hellhäutigen Menschen mit dem Potenzial, in ein kutanes Plattenepithelkarzinom (PEK) überzugehen. Beide Erkrankungen können mit erheblicher Morbidität verbunden sein und stellen eine große Krankheitslast insbesondere in der älteren Bevölkerung dar. Um eine evidenzbasierte, klinische Entscheidungsfindung zu unterstützen, wurde die Leitlinie „Aktinische Keratose und kutanes Plattenepithelkarzinom“ auf der Methodikebene S3 nach dem Regelwerk der AWMF entwickelt. Die Leitlinie richtet sich dabei an Dermatologen, Allgemeinmediziner, HNO‐Ärzte, Chirurgen, Onkologen, Radiologen und Strahlentherapeuten in Klinik und Praxis sowie an andere medizinische Fachgebiete, die sich mit der Diagnose und Behandlung von Patienten mit AK und PEK befassen. Die Leitlinie richtet sich auch an betroffene Patienten, deren Angehörige, politische Entscheidungsträger und Versicherungsgesellschaften. In diesem Teil behandeln wir die Themen Epidemiologie, Ätiologie, chirurgische und systemische Behandlung des PEK, Nachsorge des PEK, Prävention und Berufskrankheit durch AK und PEK.

show abstract

The role of suprahyoid neck dissection in the treatment of squamous cell carcinoma of the lower lip: 20 years' experience at a Tertiary Center

Cited by 11 publications

References 12 publications

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease

Neck dissection indications in lower lip squamous cell carcinoma cases: Our experience in 96 cases

S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit

Contact Info

Product

Resources

About